BYSTOLIC ARB Trademark

Trademark Overview

On Thursday, August 1, 2013, a trademark application was filed for BYSTOLIC ARB with the United States Patent and Trademark Office. The USPTO has given the BYSTOLIC ARB trademark a serial number of 86025811. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 16, 2015. This trademark is owned by Forest Laboratories, Inc.. The BYSTOLIC ARB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing beta-adrenergic blockers and angiotensin receptor blockers for the treatment of hypertension
bystolic arb

General Information

Serial Number86025811
Word MarkBYSTOLIC ARB
Filing DateThursday, August 1, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 16, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2014

Trademark Statements

Disclaimer with Predetermined Text"ARB"
Goods and ServicesPharmaceutical preparations containing beta-adrenergic blockers and angiotensin receptor blockers for the treatment of hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 9, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameForest Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameForest Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Wednesday, April 15, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 15, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 17, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 16, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 15, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 20, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 20, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 14, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 14, 2014EXAMINER'S AMENDMENT ENTERED
Monday, April 14, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 14, 2014EXAMINERS AMENDMENT E-MAILED
Monday, April 14, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, April 11, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, April 11, 2014PRIORITY ACTION E-MAILED
Friday, April 11, 2014PRIORITY ACTION WRITTEN
Friday, April 4, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, March 23, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, March 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 8, 2014ASSIGNED TO LIE
Thursday, February 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 20, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, February 20, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 20, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, February 20, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2013NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2013NON-FINAL ACTION WRITTEN
Tuesday, October 15, 2013ASSIGNED TO EXAMINER
Friday, August 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 5, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

bystolic blockers angiotensin receptor treatment hypertension adrenergic preparations containing beta pharmaceutical